Pharmaceutical

ILution travoprost by Glaukos for Open-Angle Glaucoma: Likelihood of Approval

ILution travoprost is under clinical development by Glaukos and currently in Phase II for Open-Angle Glaucoma.

Jun 20, 2024 - 04:00
ILution travoprost by Glaukos for Open-Angle Glaucoma: Likelihood of Approval
ILution travoprost is under clinical development by Glaukos and currently in Phase II for Open-Angle Glaucoma.
Read the original article

Tags:

Previous Article

Large wildfires create weather that favors more fire

Next Article

ILution travoprost by Glaukos for Ocular Hypertension: Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

SGNB-7H4V by Pfizer for Epithelial Ovarian Cancer: Likelihood of Approval

SGNB-7H4V by Pfizer for Epithelial Ovarian Cancer: Like...

Jun 20, 2024

Vivek Ramaswamy’s brashness made waves in the Republican debate. He did the same in biotech

Vivek Ramaswamy’s brashness made waves in the Republica...

Aug 25, 2023

Be Bio’s haemophilia B treatment gains FDA orphan drug status

Be Bio’s haemophilia B treatment gains FDA orphan drug ...

Jun 6, 2024